PhaseV vs Spade Therapeutics
PhaseV vs Spade Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PhaseV is on 56/100 and Spade Therapeutics on 38/100.
Where each one leads
PhaseV
- our overall score: 56/100 against 38/100
- agent readiness: 42/100 against 22/100
- funding raised: $65.0M against $40.0M
Spade Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | PhaseV | Spade Therapeutics |
|---|---|---|
| What it is | Develops a platform for adaptive clinical trial design and closed-loop execution. | Drug discovery and development company using a novel technological approach. |
| Category | Life Sciences, Clinical Trials, Optimization, HealthTech | Life Sciences, Drug Discovery, Drug Development, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2023 | 2022 |
| Headquarters | Tel Aviv, Israel | Cambridge, United States |
| Status | Active | Inactive |
Size, funding and growth
| Measure | PhaseV | Spade Therapeutics |
|---|---|---|
| Employees | 61 | Not published |
| Headcount growthLast 12 months | +173.2% | Not published |
| Total funding | $65.0M | $40.0M |
| Latest round | Series A | Series B |
| LinkedIn followers | 6,602 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PhaseV | Spade Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 38/100 |
| Traction | 57/100 | 38/100 |
| Team | 70/100 | 30/100 |
| Community | Not published | 15/100 |
| Search visibility | 40/100 | 2/100 |
| Quality | 55/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (42/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 33/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PhaseV | Spade Therapeutics |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Webflow | Not detected |
| Analytics | Google Analytics 4 | Not detected |
PhaseV vs Spade Therapeutics: common questions
Which is better, PhaseV or Spade Therapeutics?
On our 0-100 score PhaseV rates higher (56/100 against 38/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do PhaseV and Spade Therapeutics compare on the numbers?
PhaseV leads on our overall score (56/100 against 38/100), agent readiness (42/100 against 22/100), funding raised ($65.0M against $40.0M).
Read the full PhaseV review and pricing or the Spade Therapeutics review and pricing. You can also browse other PhaseV alternatives we track.